Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
FOXO Technologies ( (FOXO) ) has provided an announcement.
FOXO Technologies Inc. announced the completion of restructuring and capital raising transactions aimed at enhancing its financial standing and compliance with NYSE American listing standards. The company reduced liabilities and increased stockholders’ equity by $26.4 million, which is expected to eliminate the risk of potential delisting, and appointed Seamus Lagan as the new Chief Executive Officer to lead its growth strategy.
More about FOXO Technologies
FOXO Technologies Inc. is a biotechnology company that focuses on improving human health and lifespan through advanced technology and product solutions across various industries. The company operates subsidiaries including Foxo Labs, Inc., Myrtle Recovery Centers, Inc., and Rennova Community Health, Inc., providing services in biotechnology, behavioral health, and hospital operations.
YTD Price Performance: 53.12%
Average Trading Volume: 48,563,425
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $8.56M
See more data about FOXO stock on TipRanks’ Stock Analysis page.
